CIBC Bancorp USA’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
CIBC Bancorp USA's XENE Position: Q3 2026 in Review
CIBC Bancorp USA increased its Xenon Pharmaceuticals (XENE) stake by 79% in Q3 2026, buying an estimated $254K and bringing the position to 9,705 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.
CIBC Bancorp USA first reported a position in XENE in Q3 2025 and has held it in 4 quarters since. 284 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- CIBC Bancorp USA held 9,705 shares of Xenon Pharmaceuticals worth $361K as of Q3 2026.
- CIBC Bancorp USA bought 4,282 Xenon Pharmaceuticals shares in Q3 2026, an estimated $254K.
- Xenon Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1570 holding.
- CIBC Bancorp USA first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 284 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.